Leukocyte telomere length decreased the risk of mortality in patients with alcohol-associated liver disease

被引:0
|
作者
Yi, Jiahong [1 ]
Guo, Hui [2 ]
Jiang, Chang [1 ]
Duan, Junyi [3 ]
Xue, Ju [1 ]
Zhao, Yue [1 ]
He, Wenzhuo [1 ]
Xia, Liangping [1 ]
机构
[1] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, Guangdong Prov Clin Res Ctr Canc, Canc Ctr,Dept VIP Reg,State Key Lab Oncol South Ch, Guangzhou, Peoples R China
[2] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, Guangdong Prov Clin Res Ctr Canc, Canc Ctr,State Key Lab Oncol South China, Guangzhou, Peoples R China
[3] Jinan Univ, Zhuhai Peoples Hosp, Zhuhai Hosp, Dept Obstet & Gynecol, Zhuhai, Peoples R China
来源
关键词
alcohol-associated liver disease; all-cause mortality; leukocyte telomere length; NHANES; prognosis; SENESCENCE; HEPATITIS; PATHOGENESIS; FIBROSIS;
D O I
10.3389/fendo.2024.1462591
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: It is necessary to find latent indicators to predict the survival of alcohol-associated liver disease (ALD) patients. Leukocyte telomere length (LTL) was regarded as an indicator of prognosis in several diseases. However, the relationships between LTL and survival as well as cause-specific mortality in ALD patients were still unknown. Objective: This study aimed at exploring the underlying link between LTL and the risk of mortality in patients with ALD. Methods: The LTL and survival data were gathered from the National Health and Nutrition Examination Survey (NHANES) 1999-2002. The connection between LTL and mortality was assessed by Cox regression models and stratified analyses. The non-linear relationship was explored by restricted cubic spline (RCS) analysis. Sensitivity analyses were used to evaluate the robustness of our findings. Results: LTL was a negative factor for all-cause mortality (all p-value < 0.05). The risk of cardiovascular disease (CVD)-related death was decreased in Q3 (p < 0.001) and Q4 levels of LTL (p < 0.001) compared with the Q1 group. Shorter LTL resulted in higher cancer-caused mortality (p = 0.03) in the Q2 group. Longer LTL improved survival especially for elder patients (p for trend < 0.001) or men (p for trend = 0.001). Moreover, there were L-shaped correlations between LTL and all-cause mortality (p for non-linearity = 0.02), as well as cancer-related mortality (p for non-linearity < 0.001). Four sensitivity analyses proved the robustness of our findings. Conclusion: Our research found that longer LTL improved survival in patients with ALD and decreased CVD and cancer-related mortality. LTL decreased all-cause mortality especially for patients older than 65 years or men. LTL might be a useful biomarker for prognosis among patients with ALD. More prospective studies are needed to assess the relevance between LTL and mortality and explore the underlying mechanisms between them.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Telomere length in patients with alcohol-associated liver disease: a brief report
    Huda, Nazmul
    Kusumanchi, Praveen
    Perez, Kristina
    Jiang, Yanchao
    Skill, Nicholas J.
    Sun, Zhaoli
    Ma, Jing
    Yang, Zhihong
    Liangpunsakul, Suthat
    JOURNAL OF INVESTIGATIVE MEDICINE, 2022, 70 (06) : 1438 - 1441
  • [2] Geographic Density of Gastroenterologists Is Associated With Decreased Mortality From Alcohol-Associated Liver Disease
    Lee, Brian P.
    Dodge, Jennifer L.
    Terrault, Norah A.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (06) : 1542 - +
  • [3] IMPACT OF SARCOPENIA ON MORTALITY IN PATIENTS WITH ALCOHOL-ASSOCIATED LIVER DISEASE
    Kezer, Camille A.
    Rattan, Puru
    Lennon, Ryan J.
    Kamath, Patrick S.
    Shah, Vijay
    Simonetto, Douglas
    GASTROENTEROLOGY, 2022, 162 (07) : S1219 - S1219
  • [4] Alcohol-associated liver disease increases the risk of muscle loss and mortality in patients with cirrhosis
    Kunzler, Izadora Luiza
    Da Croce, Marco Antonio
    Fornari, Fernando
    JOURNAL OF GASTROENTEROLOGY, 2024, 59 (12) : 1143 - 1143
  • [5] Alcohol-associated liver disease increases the risk of muscle loss and mortality in patients with cirrhosis
    Hanai, Tatsunori
    Nishimura, Kayoko
    Unome, Shinji
    Miwa, Takao
    Nakahata, Yuki
    Imai, Kenji
    Suetsugu, Atsushi
    Takai, Koji
    Shimizu, Masahito
    JOURNAL OF GASTROENTEROLOGY, 2024, 59 (10) : 932 - 940
  • [6] MEDICAL THERAPY FOR ALCOHOL USE DISORDER IS ASSOCIATED WITH A DECREASED RISK OF DEVELOPING ALCOHOL-ASSOCIATED LIVER DISEASE
    Vannier, Augustin
    Fomin, Vladislav
    Diaz, Paige McLean
    Marshall, Chantelle
    Goodman, Russell
    Schaefer, Esperance
    Luther, Jay
    HEPATOLOGY, 2021, 74 : 89A - 89A
  • [7] Risk of alcohol-associated liver disease in the offspring of parents with alcohol-associated liver disease: A nationwide cohort study
    Jepsen, Peter
    West, Joe
    Kann, Anna Emilie
    Kraglund, Frederik
    Morling, Joanne
    Crooks, Colin
    Askgaard, Gro
    HEPATOLOGY, 2024, 80 (02) : 418 - 427
  • [8] Myokines are associated with progression, course and mortality in alcohol-associated liver disease
    Kaur, Parminder
    Verma, Nipun
    Garg, Pratibha
    Ralmilay, Samonee
    Wadhawan, Aishani
    Nadda, Rohit
    Prajapati, Jiya
    Sharma, Gaurav
    Rathi, Sahaj
    De, Arka
    Premkumar, Madhumita
    Taneja, Sunil
    Singal, Ashwani K.
    Duseja, Ajay
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 60 (08) : 1005 - 1020
  • [9] Alcohol-Associated Liver Disease
    Jophlin, Loretta L.
    Singal, Ashwani K.
    Shah, Vijay H.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2025, 120 (03): : 495 - 499
  • [10] Leukocyte telomere length and mortality risk in patients with type 2 diabetes
    Bonfigli, Anna Rita
    Spazzafumo, Liana
    Prattichizzo, Francesco
    Bonafe, Massimiliano
    Mensa, Emanuela
    Micolucci, Luigina
    Giuliani, Angelica
    Fabbietti, Paolo
    Testa, Roberto
    Boemi, Massimo
    Lattanzio, Fabrizia
    Olivieri, Fabiola
    ONCOTARGET, 2016, 7 (32) : 50835 - 50844